DexCom (DXCM) Tops Q1 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
Dexcom Reports First Quarter 2019 Financial Results
May 1, 2019 4:02 PM EDTSAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March31, 2019.
First Quarter 2019 Highlights:
Revenue grew 52% versus the same quarter of the prior year to $280.5 million U.S. revenue growth of 45% and international revenue growth of 79% Demonstrated additional real-world clinical benefits driven by Dexcom real-time CGM, as described in recent scientific publications: Actionable, predictive low glucose alerts with the Dexcom G6 enable further reductions in hypoglycemia, independent of... More


